Consensus Salesforce.com, Inc.

Equities

CRM

US79466L3024

Market Closed - Nyse 04:00:02 2024-02-20 pm EST Pre-market 07:19:30 pm
286.4 USD -1.15% Intraday chart for Salesforce.com, Inc. 285.4 -0.33%

Evolution of the average Target Price on Salesforce.com, Inc.

Price target over the last 5 years

History of analyst recommendation changes

80.wa2G7fs0JXm8xzsCiodnibxpdV_38J4L16DXBO2Kl_w.o-HD3pZzUA77l3hD67MK2N1bEDrOsvROpseQMabzppfsxeSsgQRPPdmtCw~24f79d6e7a9f72bcb47fc17b68fe7000
SALESFORCE : Bank of America raises guidance CF
UBS Raises Salesforce Price Target to $310 From $285, Maintains Neutral Rating MT
SALESFORCE : UBS gives a Neutral rating ZD
Wait... Not so fast! Our Logo
ANALYST RECOMMENDATIONS : PayPal, United Airlines, Nvidia, Home Depot, Wizz Air... Our Logo
A key week for refining rate cuts expectations Our Logo
Oppenheimer Raises Salesforce Price Target to $325 From $300, Maintains Outperform Rating MT
SAP: share price rises, Jefferies upgrades to buy CF
SAP with another record high - Jefferies buy recommendation DP
ANALYST RECOMMENDATIONS : Adobe, AMD, Astrazeneca, Home Depot, Netflix... Our Logo
Inflation is just the icing on the cake Our Logo
UBS Raises Salesforce Price Target to $285 From $260, Maintains Neutral Rating MT
SALESFORCE : UBS reiterates its Neutral rating ZD
Investors keep their cool despite inflation data Our Logo
Baird Upgrades Salesforce to Outperform From Neutral, Raises Price Target to $300 From $240 MT
ANALYST RECOMMENDATIONS : AMD, Broadcom, Persimmon, Salesforce, Uber... Our Logo
SALESFORCE : JP Morgan reaffirms its Buy rating ZD
Piper Sandler Raises Price Target on Salesforce to $285 From $266, Maintains Neutral Rating MT
Salesforce Upgraded by Morgan Stanley to Overweight From Equalweight, Price Target Boosted to $350 From $290 MT
ANALYST RECOMMENDATIONS : Amgen, Eli Lilly, Micron Salesforce, Texas Instruments... Our Logo
Fed officials fail to calm investors Our Logo
Wells Fargo Downgrades Salesforce to Equalweight From Overweight, Price Target is $280 MT
ANALYST RECOMMENDATIONS : AbbVie, Bank of Montreal, Lowe's, Salesforce, Zoom... Our Logo
Wolfe Research Upgrades Salesforce to Outperform From Peer Perform, $315 Price Target MT
ANALYST RECOMMENDATIONS : Abbvie, Blackrock, Chubb, JPMorgan, Salesforce... Our Logo
More recommendations

Analysts' Consensus

Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
48
Last Close Price
286.4 USD
Average target price
292.5 USD
Spread / Average Target
+2.14%
High Price Target
390 USD
Spread / Highest target
+36.18%
Low Price Target
212 USD
Spread / Lowest Target
-25.98%

Consensus detail

Consensus revision (last 18 months)

Analysts covering Salesforce.com, Inc.

UBS
Oppenheimer
Baird
JPMORGAN Mark Murphy
Piper Sandler
Morgan Stanley
Wells Fargo Securities
Wolfe Research
RBC Rishi Jaluria
BMO Capital
Wedbush
BNP Paribas Exane
Societe Generale
BofA Securities
Macquarie
Goldman Sachs
Deutsche Bank Securities
RBC Capital Markets
TD Cowen
Canaccord Genuity
Mizuho Securities
JPMorgan Chase
JMP Securities
Barclays
Needham & Co.
DEUTSCHE BANK RESEARCH Brad Zelnick
JEFFERIES Brent Thill
Citigroup
KeyBanc Capital Markets
HSBC
Northland Securities
Jefferies & Co.
FBN Securities
Roth MKM
Loop Capital
Truist Securities
Evercore ISI
Stifel Nicolaus
Morningstar
Raymond James
Bernstein
SMBC Nikko
Atlantic Equities
DA Davidson
Cowen
BERNSTEIN RESEARCH Mark Moerdler
Credit Suisse
KGI Securities
Cleveland Research
Guggenheim
Monness, Crespi, Hardt
Roth Capital Partners
CICC Research
DEUTSCHE BANK
NORDLB Wolfgang Donie
Redburn
Nord/LB
BANK OF AMERICA (BOFA) Kash Rangan
Trading Rating
Investor Rating
ESG Refinitiv
B
More Ratings
+229% on MICROSOFT CORPORATION since our purchase on January 11, 2019
Replicate our performance
fermer